Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Napoleone Ferrara

Showing results (51-60 of 195) with videos related to

Pageof 20
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|October 11, 2018
Metastatic growth instructed by neutrophil-derived transferrinWei Liang, Qin Li, Napoleone Ferrara
Nature Reviews. Drug Discovery|April 11, 2023
Targeting angiogenesis in oncology, ophthalmology and beyondYihai Cao, Robert Langer, Napoleone Ferrara
Nature Medicine|September 3, 2002
Endocrine gland-derived VEGF and the emerging hypothesis of organ-specific regulation of angiogenesisJennifer LeCouter, Rui Lin, Napoleone Ferrara
Annals of the New York Academy of Sciences|May 22, 2004
EG-VEGF: a novel mediator of endocrine-specific angiogenesis, endothelial phenotype, and functionJennifer Lecouter, Rui Lin, Napoleone Ferrara
Endocrine Research|January 18, 2003
Endocrine gland vascular endothelial growth factor (EG-VEGF) and the hypothesis of tissue-specific regulation of angiogenesisNapoleone Ferrara, Jennifer LeCouter, Rui Lin
Biochemical and Biophysical Research Communications|June 18, 2005
Bevacizumab (Avastin), a humanized anti-VEGF monoclonal antibody for cancer therapyNapoleone Ferrara, Kenneth J Hillan, William Novotny
Nature Reviews. Cancer|June 25, 2010
Targeting the tumour vasculature: insights from physiological angiogenesisAlicia S Chung, John Lee, Napoleone Ferrara
The FEBS Journal|October 21, 2022
Endothelial cell diversity: the many facets of the crystalLorena Perez-Gutierrez, Pin Li, Napoleone Ferrara
Experimental Biology and Medicine (Maywood, N.J.)|October 25, 2006
Paracrine VEGF/VE-cadherin action on ovarian cancer permeabilityLimin Hu, Napoleone Ferrara, Robert B Jaffe
Biochemical and Biophysical Research Communications|April 20, 2011
Comparing protein VEGF inhibitors: In vitro biological studiesLanlan Yu, Xiao Huan Liang, Napoleone Ferrara
Pageof 20

Showing results (51-60 of 195) with videos related to

Sort By:
Pageof 20
Proceedings of the National Academy of Sciences of the United States of America|October 11, 2018
Metastatic growth instructed by neutrophil-derived transferrinWei Liang, Qin Li, Napoleone Ferrara
Nature Reviews. Drug Discovery|April 11, 2023
Targeting angiogenesis in oncology, ophthalmology and beyondYihai Cao, Robert Langer, Napoleone Ferrara
Nature Medicine|September 3, 2002
Endocrine gland-derived VEGF and the emerging hypothesis of organ-specific regulation of angiogenesisJennifer LeCouter, Rui Lin, Napoleone Ferrara
Annals of the New York Academy of Sciences|May 22, 2004
EG-VEGF: a novel mediator of endocrine-specific angiogenesis, endothelial phenotype, and functionJennifer Lecouter, Rui Lin, Napoleone Ferrara
Endocrine Research|January 18, 2003
Endocrine gland vascular endothelial growth factor (EG-VEGF) and the hypothesis of tissue-specific regulation of angiogenesisNapoleone Ferrara, Jennifer LeCouter, Rui Lin
Biochemical and Biophysical Research Communications|June 18, 2005
Bevacizumab (Avastin), a humanized anti-VEGF monoclonal antibody for cancer therapyNapoleone Ferrara, Kenneth J Hillan, William Novotny
Nature Reviews. Cancer|June 25, 2010
Targeting the tumour vasculature: insights from physiological angiogenesisAlicia S Chung, John Lee, Napoleone Ferrara
The FEBS Journal|October 21, 2022
Endothelial cell diversity: the many facets of the crystalLorena Perez-Gutierrez, Pin Li, Napoleone Ferrara
Experimental Biology and Medicine (Maywood, N.J.)|October 25, 2006
Paracrine VEGF/VE-cadherin action on ovarian cancer permeabilityLimin Hu, Napoleone Ferrara, Robert B Jaffe
Biochemical and Biophysical Research Communications|April 20, 2011
Comparing protein VEGF inhibitors: In vitro biological studiesLanlan Yu, Xiao Huan Liang, Napoleone Ferrara
Pageof 20